Reference Dose for Methylmercury (External Review Draft, 2000)

Notice - This site contains archived material(s)

Archive disclaimer
Archive disclaimer
Archived files are provided for reference purposes only. These files are no longer maintained by the Agency and may be outdated. For current EPA information, go to It is EPA's policy to support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact EPA's Reasonable Accommodations or submit a request using the Contact Us form.


In 1997, U.S. EPA issued the Mercury Study Report to Congress (MSRC). Among the assessments in the MSRC was a state-of-the-science evaluation of the health effects of methylmercury. There has been considerable discussion within the scientific community regarding the level of exposure to methylmercury that is likely to be without appreciable risk of adverse health effects. Congress directed EPA through the House Appropriations Report for FY99 to contract with the National Research Council to evaluate the body of data on the health effects of methylmercury, with particular emphasis on new data since the 1997 Mercury Study Report to Congress, and provide recommendations regarding issues relevant to the derivation of an appropriate RfD for methylmercury. EPA has thoroughly reviewed this document, and concurs with the NRC findings and recommendations. The NRC document is used as the basis for the current EPA derivation of the RfD for methylmercury.

Methylmercury is a highly toxic substance; there are a number of adverse health effects associated with methylmercury exposure. Most extensive are the data for neurotoxicity, particularly in developing organisms. Therefore the brain is considered to be the most sensitive target organ for which there are data suitable for derivation of an RfD. The NRC considered three epidemiological longitudinal developmental studies suitable for quantitative risk assessment: the Seychelles Islands, the Faroe Islands, and New Zealand. The Seychelles study has yielded no evidence of impairment related to methylmercury exposure, while both the other studies have found dose-related adverse effects on a number of neuropsychological endpoints. The Faroe Islands study, the larger of the latter two studies, has been extensively peer-reviewed and is used for the derivation of the RfD. The NRC's major finding is that the results of the Faroe Islands study provide scientifically credible basis on which to base EPA's RfD.

The RfD derived in this assessment is 0.1 ug/kg per day. This is the same as the RfD derived by EPA in 1995 based on an earlier study of a poisoning episode in Iraq, in which data on adverse neurological effects in infants was used as the point of departure for derivation of the RfD.


U.S. EPA. Reference Dose for Methylmercury (External Review Draft, 2000). U.S. Environmental Protection Agency, Washington, D.C., NCEA-S-0930.


Date Description
01-Dec 1997EPA released the Mercury Study Report to Congress.
02-Oct 2000EPA released a draft, Reference Dose for Methylmercury for a 30-day public review and comment.
03-Nov 2000EPA held an independent peer review of the document on November 15, 2000.

This download(s) is distributed solely for the purpose of pre-dissemination peer review under applicable information quality guidelines. It has not been formally disseminated by EPA. It does not represent and should not be construed to represent any Agency determination or policy.